PubRank

R E Pounder

Author PubWeight™ 212.60‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Is measles vaccination a risk factor for inflammatory bowel disease? Lancet 1995 6.75
2 Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet 1989 5.70
3 A simple clinical colitis activity index. Gut 1998 4.35
4 Effect of cimetidine on 24-hour intragastric acidity in normal subjects. Gut 1976 3.75
5 Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity. Gut 1984 3.18
6 24-hour control of intragastric acidity by cimetidine in duodenal-ulcer patients. Lancet 1975 2.67
7 Genetics versus environment in inflammatory bowel disease: results of a British twin study. BMJ 1996 2.64
8 Paramyxovirus infections in childhood and subsequent inflammatory bowel disease. Gastroenterology 1999 2.39
9 Effect of daily oral omeprazole on 24 hour intragastric acidity. Br Med J (Clin Res Ed) 1983 2.30
10 Detection of herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reaction. J Med Virol 1992 2.22
11 Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut 1990 2.13
12 Transmucosal penetration of bismuth particles in the human stomach. Gastroenterology 1992 2.00
13 Model of medical treatment for duodenal ulcer. Lancet 1981 1.98
14 Evaluation of the polymerase chain reaction for detecting the urease C gene of Helicobacter pylori in gastric biopsy samples and dental plaque. J Med Microbiol 1993 1.94
15 24-hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer during oral administration of cimetidine and atropine. Gut 1977 1.87
16 Inhibition of food-stimulated gastric acid secretion by cimetidine. Gut 1976 1.82
17 DNA patterns of Helicobacter pylori isolated from gastric antrum, body, and duodenum. Gastroenterology 1992 1.80
18 A survey of dyspepsia in Great Britain. Aliment Pharmacol Ther 1996 1.79
19 Evidence of persistent measles virus infection in Crohn's disease. J Med Virol 1993 1.76
20 Inherited disorders of coagulation appear to protect against inflammatory bowel disease. Gastroenterology 1995 1.69
21 Serum -glytamyl transpeptidase activity in liver disease. Gut 1972 1.69
22 Macrophage heterogeneity in normal colonic mucosa and in inflammatory bowel disease. Gut 1988 1.67
23 The absorption of bismuth from oral doses of tripotassium dicitrato bismuthate. Aliment Pharmacol Ther 1989 1.65
24 Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole. Aliment Pharmacol Ther 1987 1.62
25 Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole. Br Med J (Clin Res Ed) 1984 1.61
26 Is proximal demarcation of ulcerative colitis determined by the territory of the inferior mesenteric artery? Lancet 1995 1.58
27 Bismuth accumulates in the body during treatment with tripotassium dicitrato bismuthate. Aliment Pharmacol Ther 1989 1.52
28 Healing of gastric ulcer during treatment with cimetidine. Lancet 1976 1.52
29 The effect of ranitidine, cimetidine or famotidine on low-dose post-prandial alcohol absorption. Aliment Pharmacol Ther 1991 1.51
30 Helicobacter pylori and gastroduodenal secretory function. Gastroenterology 1996 1.50
31 Perinatal and childhood risk factors for inflammatory bowel disease: a case-control study. Eur J Gastroenterol Hepatol 1995 1.46
32 The initial care of newborn infants and subsequent hay fever. Allergy 2000 1.46
33 Duodenal ulcers that will not heal. Gut 1984 1.45
34 Measles IgM immunoreactivity in patients with inflammatory bowel disease. Ital J Gastroenterol Hepatol 1998 1.44
35 Twenty-four hour intragastric acidity and plasma gastrin concentration profiles in female and male subjects. Clin Sci (Lond) 1991 1.42
36 Review article: the pharmacological implications of leucocyte-endothelial cell interactions in Crohn's disease. Aliment Pharmacol Ther 1991 1.40
37 Management issues for debate: the problems in perspective. Aliment Pharmacol Ther 1993 1.39
38 Twenty-four-hour intragastric acidity and plasma gastrin concentration in healthy subjects and patients with duodenal or gastric ulcer, or pernicious anaemia. Aliment Pharmacol Ther 1987 1.35
39 A randomized placebo-controlled trial of a humanized monoclonal antibody to alpha4 integrin in active Crohn's disease. Gastroenterology 2001 1.34
40 Antineutrophil cytoplasm autoantibodies against bactericidal/permeability-increasing protein in inflammatory bowel disease. Gut 1997 1.23
41 Infant mortality and the incidence of inflammatory bowel disease. Lancet 1997 1.23
42 Comparison of PCR-based restriction length polymorphism analysis of urease genes with rRNA gene profiling for monitoring Helicobacter pylori infections in patients on triple therapy. J Clin Microbiol 1994 1.22
43 Relief of duodenal ulcer sysmptons by oral metiamide. Br Med J 1975 1.20
44 Clostridium difficile and inflammatory bowel disease. Gut 1983 1.20
45 The value of rectal biopsy in distinguishing self-limited colitis from early inflammatory bowel disease. Q J Med 1987 1.18
46 Eradication of Helicobacter pylori abolishes 24-hour hypergastrinaemia: a prospective study in healthy subjects. Aliment Pharmacol Ther 1991 1.17
47 Letter: Serum lysozyme in inflammatory bowel disease. Lancet 1975 1.16
48 Early mucosal changes in Crohn's disease. Gut 1993 1.16
49 Intestinal permeability and function in patients infected with human immunodeficiency virus. A comparison with coeliac disease. Scand J Gastroenterol 1993 1.15
50 Red cell abnormalities associated with sulphasalazine maintenance therapy for ulcerative colitis. Gut 1975 1.15
51 Persistent measles virus infection of the intestine: confirmation by immunogold electron microscopy. Gut 1995 1.10
52 Value of brush cytology in diagnosis of gastric cancer. Br Med J 1975 1.09
53 Mucosal capillary thrombi in rectal biopsies. Histopathology 1992 1.09
54 Review article: the pharmacology of rabeprazole. Aliment Pharmacol Ther 1999 1.09
55 A placebo-controlled trial to assess the effects of 8 days of dosing with rabeprazole versus omeprazole on 24-h intragastric acidity and plasma gastrin concentrations in young healthy male subjects. Aliment Pharmacol Ther 1998 1.09
56 Tolerance during 29 days of conventional dosing with cimetidine, nizatidine, famotidine or ranitidine. Aliment Pharmacol Ther 1990 1.08
57 Asian ethnic origin and the risk of inflammatory bowel disease. Eur J Gastroenterol Hepatol 1999 1.08
58 Effect of eradication of Helicobacter pylori on gastric epithelial cell proliferation. Aliment Pharmacol Ther 1994 1.07
59 Proceedings: New histamine H2-receptor antagonist inhibits food-stimulated gastric acid secretion. Gut 1975 1.06
60 A distinct subset of chemokines dominates the mucosal chemokine response in inflammatory bowel disease. Aliment Pharmacol Ther 2005 1.06
61 Adult idiopathic pulmonary haemosiderosis and coeliac disease. Q J Med 1981 1.05
62 Crohn's disease: pathogenesis and persistent measles virus infection. Gastroenterology 1995 1.05
63 Conservation of the cag pathogenicity island of Helicobacter pylori: associations with vacuolating cytotoxin allele and IS605 diversity. Gastroenterology 1999 1.03
64 The effects of famotidine, 40 mg at night, on 24-hour intragastric acidity and plasma gastrin concentration in healthy subjects. Scand J Gastroenterol 1988 1.01
65 Evidence for activation of coagulation in Crohn's disease. Blood Coagul Fibrinolysis 1992 1.00
66 Thrombotic vascular risk factors in inflammatory bowel disease. Gut 1996 1.00
67 Early histological features of small intestinal injury induced by indomethacin. Aliment Pharmacol Ther 1993 1.00
68 A pilot study of treatment of active ulcerative colitis with natalizumab, a humanized monoclonal antibody to alpha-4 integrin. Aliment Pharmacol Ther 2002 1.00
69 Phase II study of anti-gastrin-17 antibodies, raised to G17DT, in advanced pancreatic cancer. J Clin Oncol 2002 1.00
70 Vascular anatomy defines sites of indomethacin induced jejunal ulceration along the mesenteric margin. Gut 1997 0.99
71 Measles virus RNA is not detected in inflammatory bowel disease using hybrid capture and reverse transcription followed by the polymerase chain reaction. J Med Virol 1998 0.99
72 Prevalence of gastrointestinal diseases in two British national birth cohorts. Gut 2003 0.98
73 In situ immune responses in Crohn's disease: a comparison with acute and persistent measles virus infection. J Med Virol 1997 0.97
74 Measles vaccination and inflammatory bowel disease: a national British Cohort Study. Am J Gastroenterol 2000 0.96
75 Short report: the absorption of fluconazole and itraconazole under conditions of low intragastric acidity. Aliment Pharmacol Ther 1993 0.96
76 24 hour intragastric acidity during maintenance treatment with ranitidine. Br Med J (Clin Res Ed) 1984 0.95
77 Short report: the effect of ranitidine on the post-prandial absorption of a low dose of alcohol. Aliment Pharmacol Ther 1992 0.95
78 Cyclosporin for Crohn's disease. Lancet 1984 0.94
79 Pre-ulcerative villous contraction and microvascular occlusion induced by indomethacin in the rat jejunum: a detailed morphological study. Aliment Pharmacol Ther 1995 0.94
80 Histamine H2-receptor antagonists and gastric acid secretion. Pharmacol Ther 1984 0.94
81 Helicobacter pylori: from the benign to the malignant. Am J Gastroenterol 1999 0.93
82 Acute indomethacin-induced jejunal injury in the rat: early morphological and biochemical changes. Gastroenterology 1994 0.92
83 Medical outpatients: changes that can benefit patients. Clin Med 2004 0.92
84 Early determinants of inflammatory bowel disease: use of two national longitudinal birth cohorts. Eur J Gastroenterol Hepatol 2000 0.92
85 Prevalence of inflammatory bowel disease in British 26 year olds: national longitudinal birth cohort. BMJ 1998 0.92
86 Twenty four hour intragastric acidity and plasma gastrin concentration in healthy volunteers taking nizatidine 150 mg, nizatidine 300 mg, ranitidine 300 mg, or placebo at 21:00 h. Gut 1988 0.91
87 Audit of endoscopic surveillance biopsy specimens in HIV positive patients with gastrointestinal symptoms. Gut 1993 0.91
88 Rapid urease test provides specific identification of Campylobacter pylori in antral mucosal biopsies. Postgrad Med J 1988 0.91
89 Tolerance during 8 days of high-dose H2-blockade: placebo-controlled studies of 24-hour acidity and gastrin. Aliment Pharmacol Ther 1990 0.90
90 Controlled comparison of cimetidine and carbenoxolone sodium in gastric ulcer. Br Med J 1979 0.90
91 Management of NSAID induced gastrointestinal disturbance. Ann Rheum Dis 1987 0.90
92 Nocturnal intragastric acidity during and after a period of dosing with either ranitidine or omeprazole. Gastroenterology 1991 0.90
93 Behavioural techniques in the management of aerophagia in patients with hiatus hernia. J Psychosom Res 1983 0.90
94 Siblings and the risk of inflammatory bowel disease. Scand J Gastroenterol 2002 0.89
95 Smoking in adults and passive smoking in children are associated with acute appendicitis. Lancet 1999 0.89
96 Smoking, the oral contraceptive pill, and Crohn's disease. Dig Dis Sci 1991 0.88
97 Omeprazole and accelerated onset of atrophic gastritis. Gastroenterology 2000 0.88
98 Localization of the beta(beta)3-adrenoceptor in the human gastrointestinal tract: an immunohistochemical study. Aliment Pharmacol Ther 1998 0.88
99 Omeprazole and liver function tests. Lancet 1983 0.88
100 Sufotidine 600 mg bd virtually eliminates 24 hour intragastric acidity in duodenal ulcer subjects. Gut 1990 0.87
101 Eradication of Helicobacter pylori and non-ulcer dyspepsia. Lancet 2000 0.87
102 DNA fingerprints of Helicobacter pylori before and after treatment with omeprazole. J Clin Pathol 1992 0.87
103 Immunohistological studies of surface antigen on colonic lymphoid cells in normal and inflamed mucosa. Comparison of follicular and lamina propria lymphocytes. Gastroenterology 1990 0.87
104 Inter-individual and intra-individual variability of ethanol concentration-time profiles: comparison of ethanol ingestion before or after an evening meal. Br J Clin Pharmacol 1995 0.86
105 The beta 3-adrenoceptor agonist CL316243 prevents indomethacin-induced jejunal ulceration in the rat by reversing early villous shortening. J Pathol 1996 0.86
106 Gastric mucosal contraction and vascular injury induced by indomethacin precede neutrophil infiltration in the rat. Gut 1996 0.86
107 Prognosis and prognostic factors in inflammatory bowel disease. Saudi J Gastroenterol 1995 0.85
108 Cyclosporin for Crohn's disease. Aliment Pharmacol Ther 1987 0.85
109 Absence of Escherichia coli, Listeria monocytogenes, and Klebsiella pneumoniae antigens within inflammatory bowel disease tissues. J Clin Pathol 1998 0.85
110 Focal reduction of villous blood flow in early indomethacin enteropathy: a dynamic vascular study in the rat. Gut 1998 0.85
111 Ulceration of the ileum in Crohn's disease: correlation with vascular anatomy. J Clin Pathol 1997 0.84
112 A microscopic and immunodiagnostic search for giardiasis in patients with gastrointestinal disorders. Scand J Gastroenterol 1988 0.84
113 Ranitidine, cimetidine, famotidine have no effect on post-prandial absorption of ethanol 0.8 g/kg taken after an evening meal. Aliment Pharmacol Ther 1992 0.84
114 Patients consulting with Crohn's disease in primary care in England and Wales. Eur J Gastroenterol Hepatol 1998 0.84
115 Seven-day treatment for Helicobacter pylori infection: ranitidine bismuth citrate plus clarithromycin and tetracycline hydrochloride. Aliment Pharmacol Ther 1997 0.83
116 The effect of GR122311X, a bismuth compound with H2-antagonist activity, on 24-hour intragastric acidity. Aliment Pharmacol Ther 1991 0.83
117 The safety and efficacy of ranitidine bismuth citrate in combination with antibiotics for the eradication of Helicobacter pylori. Aliment Pharmacol Ther 1996 0.83
118 Detection and comparative analysis of persistent measles virus infection in Crohn's disease by immunogold electron microscopy. J Clin Pathol 1997 0.83
119 Similarities between ileal Crohn's disease and indomethacin experimental jejunal ulcers in the rat. Aliment Pharmacol Ther 2000 0.82
120 The timing of the evening meal affects the pattern of 24-hour intragastric acidity. Aliment Pharmacol Ther 1990 0.82
121 Autoimmunity in ulcerative colitis: tropomyosin is not the major antigenic determinant of the Das monoclonal antibody, 7E12H12. Clin Exp Immunol 1995 0.82
122 Propranolol, oxprenolol, and sclerosing peritonitis. Br Med J (Clin Res Ed) 1982 0.82
123 Intravenous pentagastrin can induce the illusion of 'tolerance' to a single dose of an H2-blocker in man. Aliment Pharmacol Ther 1990 0.82
124 Short report: twenty-four-hour hyperpepsinogenaemia in Helicobacter pylori-positive subjects is abolished by eradication of the infection. Aliment Pharmacol Ther 1992 0.81
125 Effects of H2-receptor antagonists on blood alcohol levels. JAMA 1992 0.81
126 The modern treatment of peptic ulceration. Practitioner 1981 0.81
127 The intracellular polymerase chain reaction for small CMV genomic sequences within heavily infected cellular sections. J Pathol 1995 0.81
128 The effect of histamine H2-receptor blockade on bismuth absorption from three ulcer-healing compounds. Gastroenterology 1991 0.81
129 Crohn's disease and anastomotic recurrence: microvascular ischaemia and anastomotic healing in an animal model. Br J Surg 1993 0.81
130 Neuroendocrine islet cell tumour producing gastrin and ACTH in a patient with calcifying chronic pancreatitis. Gut 1985 0.81
131 Loperamide, diphenoxylate, and codeine phosphate in chronic diarrhoea. Br Med J 1980 0.81
132 Ranitidine has no effect on postbreakfast ethanol absorption. Am J Gastroenterol 1993 0.81
133 Factor XIIIA subunit and Crohn's disease. Gut 1993 0.81
134 Observations on the ox cell haemolysins in human serum. Clin Exp Immunol 1967 0.81
135 Has cimetidine revolutionised the medical treatment of peptic ulceration? J Hum Nutr 1979 0.81
136 Neuroendocrine changes in rat stomach during experimental diabetes mellitus. Dig Dis Sci 1992 0.80
137 Haemorrhage through the ampulla of Vater. Postgrad Med J 1985 0.80
138 The effect of fasting on 24-hour intragastric acidity and plasma gastrin concentration. Am J Gastroenterol 1991 0.80
139 Laser assisted ratio analyser 13C-urea breath testing, for the detection of H. pylori: A prospective diagnostic European multicentre study. Aliment Pharmacol Ther 1999 0.80
140 A controlled study of faecal distribution in ulcerative colitis and proctitis. Scand J Gastroenterol 1987 0.80
141 Inflammatory bowel disease and laterality: is left handedness a risk? Gut 2001 0.80
142 Effect of ranitidine bismuth citrate on postprandial plasma gastrin and pepsinogens. Gut 1993 0.80
143 Ulceration, fibrosis and diaphragm-like lesions in the caecum of rats treated with indomethacin. Aliment Pharmacol Ther 1994 0.79
144 Intestinal disaccharidase activity in human immunodeficiency virus disease. Scand J Gastroenterol 1995 0.79
145 The absorption of bismuth and salicylate from oral doses of Pepto-Bismol (bismuth salicylate). Aliment Pharmacol Ther 1990 0.79
146 Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade. Gut 1991 0.79
147 Proceedings: The value of brush cytology in the diagnosis of gastric cancer. Gut 1975 0.79
148 Gastric secretion and peptic ulceration in cirrhosis. J Hepatol 1993 0.79
149 Proceedings: The 24-hour control of intragastric pH by cimetidine, a new H2-receptor antagonist, in normal subjects and in patients with duodenal ulcer. Gut 1975 0.79
150 Effects of ranitidine 150 mg four times a day on 24-hour intragastric acidity and 24-hour plasma gastrin concentration. Dig Dis Sci 1994 0.78
151 Comparison of one-day oral dosing with three bismuth compounds for the suppression of Helicobacter pylori assessed by the 13C-urea breath test. Aliment Pharmacol Ther 1992 0.78
152 Demonstration of new sites of expression of the CCK-B/gastrin receptor in pancreatic acinar AR42J cells using immunoelectron microscopy. Regul Pept 1999 0.78
153 Serum concentrations of von Willebrand factor and soluble thrombomodulin indicate alteration of endothelial function in inflammatory bowel diseases. Dig Dis Sci 1995 0.78
154 Procoagulant and prothrombotic responses of human endothelium to indomethacin and endotoxin in vitro. Relevance to non-steroidal anti-inflammatory drug enteropathy. Scand J Gastroenterol 1995 0.78
155 What are appropriate end-points for Helicobacter pylori eradication in the treatment of duodenal ulcer? Drugs 1998 0.78
156 Measles virus induction of human endothelial cell tissue factor procoagulant activity in vitro. J Gen Virol 1994 0.78
157 A vascular hypersensitivity model of acute multifocal gastrointestinal infarction. Dig Dis Sci 1994 0.78
158 Reversal and protection against indomethacin-induced blood stasis and mucosal damage in the rat jejunum by a beta3-adrenoceptor agonist. Aliment Pharmacol Ther 1998 0.78
159 Twenty-four-hour intragastric acidity and clinical trial of bedtime enprostil 70 micrograms compared with ranitidine 300 mg in duodenal ulcer. Aliment Pharmacol Ther 1987 0.77
160 Crohn's disease, measles, and measles vaccination: a case-control failure. Lancet 1996 0.77
161 Eradication of Helicobacter pylori increases nocturnal intragastric acidity during dosing with rabeprazole, omeprazole, lansoprazole and placebo. Aliment Pharmacol Ther 2003 0.77
162 Morning versus evening dosing of lansoprazole 30 mg daily on twenty-four-hour intragastric acidity in healthy subjects. Aliment Pharmacol Ther 1996 0.77
163 A placebo-controlled study to assess the effects of 7-day dosing with 10, 20 and 40 mg rabeprazole on 24-h intragastric acidity and plasma gastrin in healthy male subjects. Aliment Pharmacol Ther 2000 0.77
164 Gastric persorption of bismuth from ranitidine bismuth citrate. Aliment Pharmacol Ther 1995 0.77
165 Dexamethasone promotes ulcer plugging in experimental enteritis. Aliment Pharmacol Ther 1994 0.77
166 Reduction of intragastric acidity in duodenal ulcer. Cimetidine or surgery? Acta Gastroenterol Belg 1979 0.77
167 Intestinal site-dependent susceptibility to chronic indomethacin in the rat: a morphological and biochemical study. Aliment Pharmacol Ther 1995 0.77
168 Tolerance during 5 months of dosing with ranitidine, 150 mg nightly: a placebo-controlled, double-blind study. Gastroenterology 1991 0.77
169 Serum immunoglobulin G reactive with endothelial cells in inflammatory bowel disease. Dig Dis Sci 1994 0.77
170 The effect of omeprazole dosing on the isolation of Helicobacter pylori from gastric aspirates. Aliment Pharmacol Ther 1999 0.76
171 A ferret model of acute multifocal gastrointestinal infarction. Gastroenterology 1992 0.76
172 Detection of herpesvirus DNA in cottontop tamarins: no association with colitis. Int J Exp Pathol 1995 0.76
173 The colonic mesenteric margin is most susceptible to injury in an experimental model of colonic ulceration. Aliment Pharmacol Ther 1999 0.76
174 Mycobacterial granulomatous inflammation in the ulcerated caecum of indomethacin-treated rats. Int J Exp Pathol 1995 0.76
175 Measles vaccination and inflammatory bowel disease. Lancet 1997 0.76
176 Endothelial changes precede mucosal ulceration induced by indomethacin: an experimental study in the rat. Aliment Pharmacol Ther 2000 0.76
177 Severe ulcerative colitis during successful pregnancy. Postgrad Med J 1983 0.76
178 Crohn's disease: the case for measles virus. Ital J Gastroenterol Hepatol 1999 0.76
179 Measles virus in Crohn's disease. Lancet 1995 0.76
180 Pancreatic exocrine deficiency, chronic active hepatitis and familial autoallergic haemolytic anaemia. Proc R Soc Med 1974 0.76
181 Extramedullary haemopoiesis in the small bowel. Gut 1986 0.75
182 Clofibrate raises human 24 h intragastric acidity but does not affect plasma gastrin concentration. Br J Clin Pharmacol 1990 0.75
183 Intramuscular cimetidine is safe and acceptable. Br Med J (Clin Res Ed) 1981 0.75
184 Absence of a gastrin inhibitory factor in the IgG fraction of serum from patients with pernicious anaemia. Gut 1990 0.75
185 Soil exposure no protection against atopy. Immunol Today 1999 0.75
186 Alimentary tract granulomas. Postgrad Med J 1991 0.75
187 The effects of low doses of ranitidine on intragastric acidity in healthy men. Aliment Pharmacol Ther 1998 0.75
188 A double-blind crossover comparison of lidamidine, loperamide and placebo for the control of chronic diarrhoea. Aliment Pharmacol Ther 1988 0.75
189 Gastric epithelial cell proliferation and histological damage after hypertonic sodium chloride: the effect of variation in the strain of rat. Int J Exp Pathol 1992 0.75
190 D-penicillamine does not increase urinary bismuth excretion in patients treated with tripotassium dicitrato bismuthate. Br J Clin Pharmacol 1990 0.75
191 Six years of H2-antagonists. Acta Gastroenterol Belg 1979 0.75
192 Comparison of three RNA amplification methods as sources of DNA for sequencing. Biotechniques 1998 0.75
193 The effect of SK&F 94482 (BMY-25368) on 24-hour intragastric acidity and plasma gastrin concentration in healthy subjects. Aliment Pharmacol Ther 1989 0.75
194 Direct in situ reverse transcriptase polymerase chain reaction for detection of measles virus. J Virol Methods 1996 0.75
195 Enprostil inhibits post-prandial gastrin release: a dose-response study. Aliment Pharmacol Ther 1988 0.75
196 Effect of oral famotidine on 24-hour intragastric acidity. Postgrad Med J 1986 0.75
197 Beta(beta)3-adrenergic receptors in human pancreatic islet and duodenal somatostatin neuroendocrine cells. Aliment Pharmacol Ther 2000 0.75
198 Leukocyte-endothelial cell interactions: potential targets for mesalazine in Crohn's disease. Adv Exp Med Biol 1995 0.75
199 Short report: plasma aluminium concentration and 24-hour urinary aluminium excretion before, during and after treatment with sucralfate. Aliment Pharmacol Ther 1991 0.75
200 The use of the polaroid camera for gastrointestinal endoscopy. J Audiov Media Med 1984 0.75
201 Disseminated infection associated with corticosteroid therapy after transduodenal sphincteroplasty. J Infect 1985 0.75
202 Letter: Danger of aspirin during pelvic irradiation. Lancet 1975 0.75
203 Twenty-four hour intragastric acidity during treatment with oral omeprazole. Scand J Gastroenterol Suppl 1986 0.75
204 Control of intragastric acidity with over-the-counter doses of ranitidine or famotidine. Aliment Pharmacol Ther 2001 0.75
205 Cryptosporidium search in idiopathic inflammatory bowel disease. J Clin Gastroenterol 1987 0.75
206 [Histamine 2 receptor antagonists in the treatment of gastric ulcer]. G E N 1977 0.75